Key Sessions
Niklas Engler
Keynote: Next Generation Process Development and Manufacturing for Cell and Gene Therapies – Improving Efficiencies and Reducing Cost of Goods
Roche
Thomas M. Spitznagel
KEYNOTE: Strategies for Development, Manufacturing, and Supply Chain to Support a Diverse Pipeline
Macrogenics
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Day One - CET/CEST (Cent Europe Summer, GMT+2)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Day One - CET/CEST (Cent Europe Summer, GMT+2)
search
Streams
Clear
08:55 - 09:005 mins
Manufacturing & Industry 4.0
Chairperson's Opening Remarks
- Swapnil Bhargava - Senior Vice President, CMC Development and GMP Manufacturing, AbCellera
09:00 - 09:3030 mins
Manufacturing & Industry 4.0
KEYNOTE: Manufacturing Strategies for a Growing and Diverse Biologics Pipeline
- Felix Oehme - VP, Head of Biotech Strategy, Bayer Pharmaceuticals
09:30 - 10:0030 mins
Manufacturing & Industry 4.0
The Link Between Supply Chain Integrity and Auditing During and Post a Pandemic
- Jim Fries - CEO, RX-360
10:00 - 10:3030 mins
Manufacturing & Industry 4.0
Scientific Track Presentation - A Representative from Sartorius
11:00 - 11:3030 mins
Manufacturing & Industry 4.0
Outsourcing Biologics CMC Development & Manufacturing – A Big Pharma Perspective
- Ulrich Ruemenapp - Head of Launch Preparation, Bayer AG
11:30 - 12:0030 mins
Manufacturing & Industry 4.0
Digital Bioprocess Twins: Enablers for accelerated process development and model predictive control strategies
- Mark Duerkop - Chief Executive Officer, Novasign
12:00 - 12:3030 mins
Manufacturing & Industry 4.0
Scientific Track Presentation - A Representative from Korber
13:40 - 13:455 mins
Manufacturing & Industry 4.0
Chairperson's Remarks
- Fausto Artico - Global R&D Tech Head of Innovation and Data Science, GSK, UK
13:45 - 14:4560 mins
Manufacturing & Industry 4.0
Panel Discussion: Designing The Facility of the Future
- Fausto Artico - Global R&D Tech Head of Innovation and Data Science, GSK, UK
- Mark Duerkop - Chief Executive Officer, Novasign
- Tarik Senussi - Snr Director of Process, Formulation Development & MSAT, Gyroscope Therapeutics
- Mohamed Chtaini - Exec. Director, Global Biologics External Collaborations & MFG Global Technical Operations, Incyte
14:45 - 15:1530 mins
Manufacturing & Industry 4.0
Scientific Track Presentation - A Representative from Charles River
Get the latest event updates
Sign up to get the latest event updates and information.
Filter
Streams
Clear